{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:12:25Z","timestamp":1760188345783},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1988,1,1]],"date-time":"1988-01-01T00:00:00Z","timestamp":567993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[1988,1]]},"DOI":"10.1016\/0145-2126(88)90144-0","type":"journal-article","created":{"date-parts":[[2004,4,19]],"date-time":"2004-04-19T13:46:32Z","timestamp":1082382392000},"page":"257-262","source":"Crossref","is-referenced-by-count":21,"title":["\u03b1-interferon in myelodysplasia; Clinical observations and effects on nk cells"],"prefix":"10.1016","volume":"12","author":[{"given":"David W.","family":"Galvani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony B.W.","family":"Nethersell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Cawley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0145-2126(88)90144-0_BIB1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2141.1987.tb06893.x","article-title":"A randomised trial of 13-cis retinoic acid with or without cytosine arabinoside in patients with myelodysplastic syndrome","volume":"66","author":"Clark","year":"1987","journal-title":"Br. J. Haemat."},{"key":"10.1016\/0145-2126(88)90144-0_BIB2","series-title":"MRC: Trial of low dose cytosine arabinoside with or without 13-cis retinoic acid versus supportive care in myelodysplastic syndrome","author":"Mufti","year":"1987"},{"key":"10.1016\/0145-2126(88)90144-0_BIB3","first-page":"575","article-title":"Low dose cytosine arabinoside in myelodysplasia and acute myelogenous leukaemia: a review","volume":"1","author":"Bolwell","year":"1987","journal-title":"Leukemia"},{"key":"10.1016\/0145-2126(88)90144-0_BIB4","first-page":"1081","article-title":"The treatment of myelodysplastic syndromes","volume":"15","author":"Spriggs","year":"1986","journal-title":"Clin. Haemat."},{"key":"10.1016\/0145-2126(88)90144-0_BIB5","first-page":"1300","article-title":"Comparative analysis of the influences of human \u03b3, \u03b1 and \u03b2 interferons on human multipotential (CFU-GGmm), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells","volume":"131","author":"Broxmeyer","year":"1983","journal-title":"J. Immun."},{"key":"10.1016\/0145-2126(88)90144-0_BIB6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2141.1986.tb07576.x","article-title":"Chronic myelogenous leukaemia: haematological remission with alpha interferon","volume":"64","author":"Talpaz","year":"1986","journal-title":"Br. J. Haemat."},{"key":"10.1016\/0145-2126(88)90144-0_BIB7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood.V69.2.501.501","article-title":"Combinations of recombinant human interferons and retinoic acid synergistically induce differentiation of the human promyelocytic leukaemia cell line HL60","volume":"69","author":"Hemmi","year":"1987","journal-title":"Blood"},{"key":"10.1016\/0145-2126(88)90144-0_BIB8","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1182\/blood.V55.5.784.784","article-title":"Clinical and haematological fluctuations in hairy-cell leukaemia: a sequential surface marker analysis","volume":"55","author":"Cawley","year":"1980","journal-title":"Blood"},{"key":"10.1016\/0145-2126(88)90144-0_BIB9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2141.1984.tb06060.x","article-title":"Natural killer-interferon system in patients with pre-leukaemia","volume":"58","author":"Takagi","year":"1984","journal-title":"Br. J. Haemat."},{"key":"10.1016\/0145-2126(88)90144-0_BIB10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0145-2126(84)90147-4","article-title":"Natural killer cell activity and antibody-dependent cellular cytotoxicity in primary leukaemic syndrome","volume":"8","author":"Kerndrup","year":"1984","journal-title":"Leukemia Res."},{"key":"10.1016\/0145-2126(88)90144-0_BIB11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelo-dysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br. J. Haemat."},{"key":"10.1016\/0145-2126(88)90144-0_BIB12","first-page":"372","article-title":"The beneficial effects of \u03b1-interferon in hairy-cell leukaemia are not attributable to NK cell mediated cytotoxicity","volume":"1","author":"Griffiths","year":"1987","journal-title":"Leukemia"},{"key":"10.1016\/0145-2126(88)90144-0_BIB13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2141.1987.00145a.x","article-title":"\u03b1-interferon in myelodysplasia","volume":"66","author":"Galvani","year":"1987","journal-title":"Br. J. Haemat."},{"key":"10.1016\/0145-2126(88)90144-0_BIB14","first-page":"786","article-title":"Treatment of myelodysplasia with \u03b1-interferon","volume":"1","author":"Galvani","year":"1987","journal-title":"Leukemia"},{"key":"10.1016\/0145-2126(88)90144-0_BIB15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ajh.2830220305","article-title":"Myeloid cell surface phenotype in myelodysplasia: evidence for abnormal peristence of an early myeloid differentiation antigen","volume":"22","author":"Baumann","year":"1986","journal-title":"Am. J. Haemat."},{"key":"10.1016\/0145-2126(88)90144-0_BIB16","first-page":"105","article-title":"A trial of recombinant \u03b12-interferon in the myelodysplastic syndromes: clinical results","volume":"1","author":"Elias","year":"1987","journal-title":"Leukemia"},{"key":"10.1016\/0145-2126(88)90144-0_BIB17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4049\/jimmunol.129.1.126","article-title":"Inhibition of in vitro granulopoiesis by autologous allogeneic human NK cells","volume":"129","author":"Hansson","year":"1982","journal-title":"J. Immun."},{"key":"10.1016\/0145-2126(88)90144-0_BIB18","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.4049\/jimmunol.136.4.1260","article-title":"Modulation of myelopoiesis by LGL: different effects of early and late progenitor cells","volume":"136","author":"Matera","year":"1986","journal-title":"J. Immun."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0145212688901440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0145212688901440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T01:25:52Z","timestamp":1705109152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0145212688901440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,1]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1988,1]]}},"alternative-id":["0145212688901440"],"URL":"https:\/\/doi.org\/10.1016\/0145-2126(88)90144-0","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[1988,1]]}}}